Temporary Mechanical Circulatory Support Device Market Report 2025

The temporary mechanical circulatory support device market size has grown strongly in recent years. It will grow from $2.43 billion in 2024 to $2.66 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to the rising incidence of acute myocardial infarction, increasing prevalence of heart failure, expanded use of intra-aortic balloon pumps, a growing aging population, and heightened awareness of temporary support options.

The temporary mechanical circulatory support device market size is expected to see strong growth in the next few years. It will grow to $3.76 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth during the forecast period can be attributed to the rising demand for minimally invasive cardiac support, an expanding heart transplant waiting list, increasing incidence of high-risk percutaneous coronary intervention (PCI) procedures, broader adoption in pediatric cardiac care, and higher healthcare spending. Key trends in the forecast period include the integration of artificial intelligence (AI) for patient monitoring, the development of magnetically levitated pumps, advancements in biocompatible and anti-thrombotic materials, the use of 3D-printed components for customization, and innovations in cloud-connected hemodynamic analytics.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the temporary mechanical circulatory support device market in the coming years. Cardiovascular diseases (CVD) are a group of disorders affecting the heart and blood vessels, leading to conditions such as heart attacks, strokes, and hypertension. This increase is largely attributed to aging populations, as advancing age elevates the risk of heart and vascular conditions. Temporary mechanical circulatory support devices assist patients with cardiovascular diseases by providing short-term support to heart function and improving blood flow during critical conditions such as heart failure or cardiogenic shock. For instance, according to the American Heart Association, a US-based non-profit organization, approximately 942,000 people in the US died from cardiovascular disease in 2022, compared to 19.41 million deaths worldwide in 2021. Consequently, the growing incidence of cardiovascular diseases is driving expansion in the temporary mechanical circulatory support device market.

Leading companies in the temporary mechanical circulatory support device market are focusing on technological innovations, such as sensor-assisted microaxial blood pumps, to provide advanced cardiac support that enhances patient outcomes and allows precise management of critical heart conditions. Sensor-assisted microaxial blood pumps are compact, implantable devices equipped with sensors that monitor and adjust blood flow in real time, offering accurate mechanical support to the heart. For example, in October 2022, Abiomed Inc., a US-based medical device company, launched the Impella RP Flex with SmartAssist, a temporary right ventricular support pump featuring internal jugular venous access, dual sensor technology for real-time hemodynamic monitoring, and an anticoagulant-free purge system. These innovations improve patient mobility, simplify pump management, and reduce bleeding risk. The technology also enables early detection and adjustment of pump performance, supporting precise patient care.

In December 2022, Johnson & Johnson Services Inc., a US-based healthcare company, acquired Abiomed for $16.6 billion. Through this acquisition, Johnson & Johnson aims to strengthen its MedTech portfolio in the cardiovascular market by integrating Abiomed’s innovative temporary mechanical circulatory support technologies and expanding access to critical heart care worldwide. Abiomed Inc. is a US-based medical device company specializing in the development and manufacturing of temporary mechanical circulatory support devices.

Major players in the temporary mechanical circulatory support device market are Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Boston Scientific Corporation, Terumo Corporation, Getinge AB, Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, LivaNova PLC, MicroPort Scientific Corporation, Supira Medical Inc., Magenta Medical Ltd., CorWave SA, Jarvik Heart Inc., Carmat SAS, Procyrion Inc., BiVACOR Inc., CardioBridge GmbH, and BrioHealth Solutions Inc.

North America was the largest region in the temporary mechanical circulatory support device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in temporary mechanical circulatory support device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the temporary mechanical circulatory support device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A temporary mechanical circulatory support (MCS) device is a specialized medical tool designed to provide short-term assistance to the heart’s pumping function in patients with acute cardiac dysfunction or failure. It mechanically enhances blood flow and stabilizes hemodynamics until recovery, transplantation, or a more permanent intervention can be undertaken. These devices are primarily used in critical care settings to support patients during high-risk cardiac procedures, manage cardiogenic shock, or serve as a bridge to heart transplantation or durable ventricular assist device implantation.

The main categories of temporary mechanical circulatory support devices include left ventricular support devices, right ventricular support devices, and biventricular support devices. Left ventricular support devices assist or replace the pumping function of the left ventricle to maintain adequate blood flow in patients with heart failure. These devices utilize various technologies such as pneumatic systems, mechanical pumps, biomimetic devices, hybrid systems, and emerging wearable solutions. Their applications include managing cardiogenic shock, bridging to transplantation, bridging to recovery, supporting high-risk cardiac procedures, and others. Key end-users comprise hospitals, cardiac surgery centers, outpatient surgical facilities, research and academic institutions, and other healthcare organizations.

The temporary mechanical circulatory support device market research report is one of a series of new reports that provides temporary mechanical circulatory support device market statistics, including the temporary mechanical circulatory support device industry global market size, regional shares, competitors with the temporary mechanical circulatory support device market share, detailed temporary mechanical circulatory support device market segments, market trends, and opportunities, and any further data you may need to thrive in the temporary mechanical circulatory support device industry. This temporary mechanical circulatory support device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The temporary mechanical circulatory support device market consists of sales of intra-aortic balloon pump, extracorporeal membrane oxygenation device, percutaneous ventricular assist device, and centrifugal pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.